Sirenia Capital Management LP Reports New 7.7% Stake in OKYO Pharma Ltd

On May 15, 2026, Sirenia Capital Management LP and Alex Silverstein filed a Schedule 13G disclosing a new ownership stake in OKYO Pharma Ltd. As of the event date on March 31, 2026, the reporting persons beneficially own 4,054,054 ordinary shares, representing 7.7% of the company's outstanding shares. The shares are held by SILV Fund, Ltd., an investment fund managed by Sirenia. Alex Silverstein, as the managing member of Sirenia Capital Management GP LLC (the general partner of Sirenia), may also be deemed to have shared voting and dispositive power over these securities. The percentage of ownership was calculated based on an aggregate of 52,479,257 ordinary shares outstanding, accounting for recent offerings and overallotment exercises reported in March 2026. The filing indicates that the securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. This initial filing marks a significant increase from a previous position of zero shares.